DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Maraveyas A, Ettelaie C, Echrish H. , et al.
Weight-adjusted dalteparin for prevention of vascular thromboembolism in advanced pancreatic cancer patients decreases serum tissue factor and serum-mediated induction of cancer cell invasion.
Blood Coagul Fibrinolysis 2010;
21 (05) 452-458
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.